Subscribe To
Pds biotech provides business update and reports first quarter 2023 financial results
Updated data from VERSATILE-002 Phase 2 trial to be presented at ASCO 2023 Company to host conference c...
May 15, 2023, 11:30 am
Gold slips amid stronger greenback
0023 GMT — Gold prices are a tad lower, as a stronger U.S. dollar pressures prices of the precious me...
May 15, 2023, 12:44 am
Pepsico hits "sweet spot" for apac growth, macros agree
Shares of PepsiCo NASDAQ: PEP are hovering near their all-time high prices of $195.50, as the company experienced bullish momentum in fundamentals a...
May 12, 2023, 10:29 am
Gold inches back towards $2,000 mark towards the end of the week
The yellow metal is down 0.7% today to around $2,002 at the moment, with the $2,000 mark now coming bac...
May 12, 2023, 10:03 am
Colombian peso (cop) to canadian dollar (cad) exchange rate history
Sunday 30 April 2023 1 COP = 0.00029216 CAD COP CAD rate for 30/04/2023 Saturday 29 April 2023 1 COP = ...
May 7, 2023, 6:14 pm
Usdchf extends lower and toward 2023 floor
The USDCHF is pushing to new lows for the day and in the process is moving toward the lows for 2023. Those lows come between 0.8851 up to 0.8866 (see ...
May 3, 2023, 4:21 pm
Silvercrest asset management (samg) to announce first quarter 2023 results and host investor conference call
NEW YORK, April 28, 2023 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host a teleconference at 8...
April 28, 2023, 4:01 pm
Protara therapeutics announces positive preliminary data from advanced-1 phase 1a dose escalation trial of tara-002 in nmibc supporting advancement into phase 2 clinical development
Favorable tolerability observed in patients with NMIBC treated with TARA-002 in ADVANCED-1 trial Anti-t...
April 28, 2023, 12:00 pm
Lantheus and point biopharma announce fda grants fast track designation for ¹⁷⁷lu-pnt2002 for the treatment of metastatic castration resistant prostate cancer
BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to i...
April 24, 2023, 11:30 am
Infosys shares tumble 10% in india, after downbeat results last week
Shares of Infosys Ltd. 500209, -10.69% slumped nearly 11% in India on Monday, following disappointing r...
April 17, 2023, 2:29 am
Sutro: too little, too late for stro-002, but platform is interesting
STRO is playing second fiddle to perpetually second fiddle player ImmunoGen in ovarian cancer. Although there are certain positive aspects to the mole...
April 11, 2023, 1:17 pm
Verano opens zen leaf buckhannon, the company’s fifth west virginia dispensary and 126th retail location nationwide
Zen Leaf Buckhannon is located at 120 Buckhannon Crossroads near U.S. Route 119, a busy highway with an average daily traffic count of up to 50,000 ve...
March 31, 2023, 11:00 am
Intellia's (ntla) hae therapy granted rmat by the fda
Intellia Therapeutics' (NTLA) in vivo CRISPR-based investigational therapy, NTLA-2002, gets Regenerativ...
March 22, 2023, 9:57 am
Acme lithium expands its lithium project at fish lake valley in nevada by securing key land position
ACME Lithium Inc. (CSE:ACME, OTCQB:ACLHF) revealed that it has expanded its lithium project by staking 63 new claims (FLV 3 claims) encompassing aroun...
March 21, 2023, 9:01 am
The collapse of silicon valley bank will spark a wave of tech mergers as funding opportunities dry up for risky startup companies, wedbush says
"When others left the Valley in 2001/2002, SVB was the bedrock and played an instrumental role in thous...
March 14, 2023, 10:17 am
Endeavour mining ups dividend as production hits target
Endeavour Mining upped its annual dividend payout by US$60mln to US$200mln after the FTSE 100 gold miner confirmed another solid year of production. O...
March 9, 2023, 3:01 am
Intellia therapeutics: progressing pipeline signals positive outlook for investors
With multiple promising candidates in its pipeline, Intellia is well-positioned to capitalize on the growing demand for gene editing therapies. The re...
March 7, 2023, 9:06 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm